Photo: ljuba/Getty Pictures The Facilities for Medicare and Medicaid Services has proposed to delay a rule necessitating drugmakers to report...
Drugmaker
Gilead Sciences has agreed to acquire Immunomedics for about $21 billion, offering it a probable blockbuster breast most cancers drug...
